Boston Scientific Corp’s filing revealed that its EVP, Global Operations Sorenson John Bradley unloaded Company’s shares for reported $0.37 million on Jan 02 ’25. In the deal valued at $90.02 per share,4,119 shares were sold. As a result of this transaction, Sorenson John Bradley now holds 35,319 shares worth roughly $3.2 million.
Then, Sorenson John Bradley sold 2,342 shares, generating $210,449 in total proceeds. Upon selling the shares at $89.86, the EVP, Global Operations now owns 32,977 shares.
Before that, Mirviss Jeffrey B. sold 7,152 shares. Boston Scientific Corp shares valued at $642,658 were divested by the EVP&Pres, Periph Intervent at a price of $89.86 per share. As a result of the transaction, Mirviss Jeffrey B. now holds 28,454 shares, worth roughly $2.58 million.
Needham downgraded its Boston Scientific Corp [BSX] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. Mizuho also remained covering BSX and has increased its forecast on February 01, 2024 with a “Buy” recommendation from previously “Neutral” rating. Robert W. Baird started covering the stock on July 19, 2023. It rated BSX as “an Outperform”.
Price Performance Review of BSX
On Friday, Boston Scientific Corp [NYSE:BSX] saw its stock jump 1.47% to $90.69. Over the last five days, the stock has lost -0.83%. Boston Scientific Corp shares have risen nearly 1.53% since the year began. Nevertheless, the stocks have risen 57.45% over the past one year. While a 52-week high of $91.93 was reached on 01/03/25, a 52-week low of $57.33 was recorded on 01/02/25. SMA at 50 days reached $88.70, while 200 days put it at $79.73.
Levels Of Support And Resistance For BSX Stock
The 24-hour chart illustrates a support level at 89.81, which if violated will result in even more drops to 88.93. On the upside, there is a resistance level at 91.26. A further resistance level may holdings at 91.84. The Relative Strength Index (RSI) on the 14-day chart is 55.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.74%. Stochastics %K at 58.68% indicates the stock is a holding.
How much short interest is there in Boston Scientific Corp?
A steep rise in short interest was recorded in Boston Scientific Corp stocks on 2024-12-13, growing by 1.3 million shares to a total of 12.33 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 11.02 million shares. There was a rise of 10.57%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 30, 2023 when CL King began covering the stock and recommended ‘”a Buy”‘ rating along with a $64 price target.
